1 / 1
At MedGence, we understand the importance of thorough and extensive research when developing new products. That's why we're proud to offer clinical research services, dedicated to supporting our clients in their quest for breakthrough scientific advances.
Contract research for new active ingredients or formulations is an important part of product development. We recognize that access to clinical data is critical to delivering evidence-based results and ensuring the safety and efficacy of our products. Our clinical research services are designed to meet these requirements, enabling our clients to collect the necessary data and meet the eligibility criteria for New Drug Applications (NDAs).
One of the key aspects of our clinical research services is the arrangement of human trials, especially for dietary supplements. By conducting small group trials, we can assess the impact and effectiveness of these supplements on human subjects, gaining valuable insight into their potential benefits and any associated risks. Such research is critical for companies looking to bring innovative dietary supplements to market.
In addition, we offer a wide selection of clinical research, not only dietary supplements, but pharmaceuticals as well. From Phase I to Phase IV clinical studies, we ensure compliance with the stringent requirements outlined in New Drug Applications. These stages allow for continuous assessment of safety, dosing and efficacy, providing data integral to regulatory submissions.
Phase I trials primarily focus on evaluating the safety and dosage levels of the product. This early study helps identify potential side effects and determine an appropriate range of doses for continued testing. By adhering to a code of ethics and closely monitoring participants, we prioritize the well-being of our trial subjects.
Phase II trials delved deeper into the product's efficacy and safety. More participants take part in these studies to gather broader data on the effectiveness of new drugs. This stage is critical to determine whether the product is behaving as expected, paving the way for further development and refinement.
Phase III trials typically involve hundreds or even thousands of participants and provide a comprehensive assessment of a product's efficacy, safety, and potential side effects. These studies allowed us to collect robust data on a larger scale, ensure statistical significance and support the NDA submission of the product.
Finally, our clinical research services also include Phase IV trials following product approval and commercialization. These trials monitor the long-term safety and efficacy of the product, providing valuable insight into actual usage and any rare adverse events that may occur.
Through our clinical research services, we provide our clients with comprehensive, reliable solutions to support their research and development efforts. Our team of experienced professionals adheres to strict protocols and guidelines ensuring the highest quality and ethical standards.
Together, let's forge a path to breakthrough discoveries and advancements in healthcare and wellness. Contact us today to learn more about our clinical research services and how we can help you achieve a successful New Drug Application.
Our research capabilities cover both pharmaceuticals and dietary supplements, spanning from early human trials to full Phase I through Phase IV studies.
Small group trials evaluate the direct impact and effectiveness on human subjects, providing crucial data on benefits and risks before bringing supplements to market.
Phase I focuses on product safety, discovering potential side effects, evaluating appropriate dosing levels, and closely monitoring participant well-being.
Phase III involves hundreds or thousands of participants to yield robust, statistically significant evidence regarding efficacy, safety, and adverse reactions needed for regulatory submission.
Phase IV trials occur after regulatory approval and commercial release to track long-term safety, real-world efficacy, and identify rare adverse events.
